Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 741 word(s) 741 2020-12-15 07:38:22

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Tang, N. Sitosterolemia. Encyclopedia. Available online: (accessed on 12 April 2024).
Tang N. Sitosterolemia. Encyclopedia. Available at: Accessed April 12, 2024.
Tang, Nora. "Sitosterolemia" Encyclopedia, (accessed April 12, 2024).
Tang, N. (2020, December 25). Sitosterolemia. In Encyclopedia.
Tang, Nora. "Sitosterolemia." Encyclopedia. Web. 25 December, 2020.

Sitosterolemia is a condition in which fatty substances (lipids) from vegetable oils, nuts, and other plant-based foods accumulate in the blood and tissues.

genetic conditions

1. Introduction

These lipids are called plant sterols (or phytosterols). Sitosterol is one of several plant sterols that accumulate in this disorder, with a blood level 30 to 100 times greater than normal. Cholesterol, a similar fatty substance found in animal products, is mildly to moderately elevated in many people with sitosterolemia. Cholesterol levels are particularly high in some affected children. However, some people with sitosterolemia have normal cholesterol levels.

Plant sterols are not produced by the body; they are taken in as components of foods. Signs and symptoms of sitosterolemia may begin to appear early in life after foods containing plant sterols are introduced into the diet, although some affected individuals have no obvious symptoms.

In people with sitosterolemia, accumulation of fatty deposits in arteries (atherosclerosis) can occur as early as childhood. These deposits narrow the arteries and can eventually block blood flow, increasing the chance of a heart attack, stroke, or sudden death.

Some people with sitosterolemia develop small yellowish growths called xanthomas beginning in childhood. Xanthomas consist of accumulated lipids and may be located anywhere on or just under the skin, typically on the heels, knees, elbows, and buttocks. They may also occur in the bands that connect muscles to bones (tendons), including tendons of the hand and the tendon that connects the heel of the foot to the calf muscles (the Achilles tendon). Large xanthomas can cause pain, difficulty with movement, and cosmetic problems.

Joint stiffness and pain resulting from plant sterol deposits may also occur in individuals with sitosterolemia. Less often, affected individuals have blood abnormalities. Occasionally the blood abnormalities are the only signs of the disorder. The red blood cells may be broken down (undergo hemolysis) prematurely, resulting in a shortage of red blood cells (anemia). This type of anemia is called hemolytic anemia. Affected individuals sometimes have abnormally shaped red blood cells called stomatocytes. In addition, the blood cells involved in clotting, called platelets or thrombocytes, may be abnormally large (macrothrombocytopenia).

2. Frequency

Only 80 to 100 individuals with sitosterolemia have been described in the medical literature. However, researchers believe that this condition is likely underdiagnosed because mild cases often do not come to medical attention. Studies suggest that the prevalence may be at least 1 in 50,000 people.

3. Causes

Sitosterolemia is caused by mutations in the ABCG5 or ABCG8 gene. These genes provide instructions for making the two halves of a protein called sterolin. This protein is involved in eliminating plant sterols, which cannot be used by human cells.

Sterolin is a transporter protein, which is a type of protein that moves substances across cell membranes. It is found mostly in cells of the intestines and liver. After plant sterols in food are taken into intestinal cells, the sterolin transporters in these cells pump them back into the intestinal tract, decreasing absorption. Sterolin transporters in liver cells pump the plant sterols into a fluid called bile that is released into the intestine. From the intestine, the plant sterols are eliminated with the feces. This process removes most of the dietary plant sterols, and allows only about 5 percent of these substances to get into the bloodstream. Sterolin also helps regulate cholesterol levels in a similar fashion; normally about 50 percent of cholesterol in the diet is absorbed by the body.

Mutations in the ABCG5 or ABCG8 gene that cause sitosterolemia result in a defective sterolin transporter and impair the elimination of plant sterols and, to a lesser degree, cholesterol from the body. These fatty substances build up in the arteries, skin, and other tissues, resulting in atherosclerosis, xanthomas, and the additional signs and symptoms of sitosterolemia. Excess plant sterols, such as sitosterol, in red blood cells likely make their cell membranes stiff and prone to rupture, leading to hemolytic anemia. Changes in the lipid composition of the membranes of red blood cells and platelets may account for the other blood abnormalities that sometimes occur in sitosterolemia.

4. Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

5. Other Names for This Condition

  • beta-sitosterolemia

  • phytosterolaemia

  • phytosterolemia

  • plant sterol storage disease

  • sitosterolaemia


  1. Berge KE. Sitosterolemia: a gateway to new knowledge about cholesterolmetabolism. Ann Med. 2003;35(7):502-11. Review.
  2. Calandra S, Tarugi P, Speedy HE, Dean AF, Bertolini S, Shoulders CC.Mechanisms and genetic determinants regulating sterol absorption, circulating LDLlevels, and sterol elimination: implications for classification and disease risk.J Lipid Res. 2011 Nov;52(11):1885-926. doi: 10.1194/jlr.R017855.
  3. Chan J, Vandeberg JL. Hepatobiliary transport in health and disease. ClinLipidol. 2012 Apr;7(2):189-202.
  4. Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, atherosclerosis andinflammation. Atherosclerosis. 2010 Aug;211(2):361-70. doi:10.1016/j.atherosclerosis.2010.01.011.
  5. Kidambi S, Patel SB. Cholesterol and non-cholesterol sterol transporters:ABCG5, ABCG8 and NPC1L1: a review. Xenobiotica. 2008 Jul;38(7-8):1119-39. doi:10.1080/00498250802007930 . Review.
  6. Kidambi S, Patel SB. Sitosterolaemia: pathophysiology, clinical presentationand laboratory diagnosis. J Clin Pathol. 2008 May;61(5):588-94. doi:10.1136/jcp.2007.049775. Review.
  7. Niu DM, Chong KW, Hsu JH, Wu TJ, Yu HC, Huang CH, Lo MY, Kwok CF, Kratz LE, HoLT. Clinical observations, molecular genetic analysis, and treatment ofsitosterolemia in infants and children. J Inherit Metab Dis. 2010Aug;33(4):437-43. doi: 10.1007/s10545-010-9126-2.
  8. Sabeva NS, Liu J, Graf GA. The ABCG5 ABCG8 sterol transporter andphytosterols: implications for cardiometabolic disease. Curr Opin EndocrinolDiabetes Obes. 2009 Apr;16(2):172-7. Review.
  9. Salen G, Patel S, Batta AK. Sitosterolemia. Cardiovasc Drug Rev. 2002Winter;20(4):255-70. Review.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 452
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 25 Dec 2020